ClinicalTrials.Veeva

Menu

The Effect of Oxytocin on the Consolidation of Trauma-Associated Memories

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Completed

Conditions

PTSD
Intrusive Memories

Treatments

Drug: Oxytocin
Drug: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT03875391
Charite2019-Oxytocin-Study

Details and patient eligibility

About

The purpose of the study is to examine whether oxytocin and certain polygenic risk scores affect the development of intrusive memories, a cardinal symptom of PTSD.

Enrollment

217 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy female volunteers
  • German on a native level

Exclusion criteria

  • former or present disorder according to the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5)
  • any physical illnesses
  • any medication intake (except oral contraceptive)
  • history of traumatic experience, e.g. history of sexual abuse or rape
  • pregnancy or lactation period
  • follicular phase of menstrual cycle for all women not using oral contraceptives

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Triple Blind

217 participants in 2 patient groups, including a placebo group

Oxytocin and trauma film paradigm
Experimental group
Description:
Intervention: Drug: Oxytocin nasal spray
Treatment:
Drug: Oxytocin
Placebo and trauma film paradigm
Placebo Comparator group
Description:
Intervention: Drug: Placebos
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems